LCDX — Caliber Imaging & Diagnostics Share Price
Last trade - 00:00- $0.00m
- $11.66m
- $3.34m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -172.69% | ||
Financial Summary
| Year End 31st Dec | Unit | 2009 | 2010 | 2011 | 2012 | 2013 | 2014E | 2015E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2.3 | 2.63 | 3.58 | 2.43 | 3.34 | n/a | n/a | 9.76% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Caliber Imaging & Diagnostics, Inc. is a medical technology company. The Company designs, develops, and markets imaging solutions that show tissue at the cellular level. It offers in-vivo confocal microscopes designed specifically for imaging skin and other tissue. Its Rapid Cell ID technology enables scientists and physicians to characterize intact normal and abnormal cellular architecture that is otherwise invisible to the naked eye. It has developed the VivaScope, a suite of imaging products. Its telepathology system allows near real-time collaboration with remote specialists. Its clinical products include VivaScope 1500, VivaScope 2500, VivaScope 3000 and VivaNet & VivaScan. Its research products include RS-G4 Upright, RS-G4 Inverted, Specialty Confocal Microscopes and Research Software Suite. The VivaScope 1500 reflectance confocal imaging system offers a non-invasive way to image the skin in vivo from the surface to the superficial collagen layers.
Directors
- Last Annual
- December 31st, 2013
- Last Interim
- March 31st, 2014
- Incorporated
- November 3rd, 2014
- Public Since
- February 27th, 2012
- No. of Shareholders
- 150
- No. of Employees
- 28
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 8,507,374
- Address
- 100 Burtt Road,, Suite 203, ANDOVER, 01810
- Web
- https://caliberid.com/
- Phone
- +1 9784749933
- Auditors
- Marcum LLP
Similar to LCDX
Aamaxan Transport
Pink Sheets on Nasdaq
ACCUSTEM SCIENCES
Pink Sheets on Nasdaq
ADM Tronics Unlimited
Pink Sheets on Nasdaq
Advanced Biomedical Technologies
Pink Sheets on Nasdaq
Aksys
Pink Sheets on Nasdaq
FAQ
As of Today at 19:04 UTC, shares in Caliber Imaging & Diagnostics are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Caliber Imaging & Diagnostics last closed at $0.00 and the price had moved by -95.83% over the past 365 days. In terms of relative price strength the Caliber Imaging & Diagnostics share price has underperformed the S&P500 Index by -96.42% over the past year.
There is no consensus recommendation for this security.
Caliber Imaging & Diagnostics does not currently pay a dividend.
Caliber Imaging & Diagnostics does not currently pay a dividend.
Caliber Imaging & Diagnostics does not currently pay a dividend.
To buy shares in Caliber Imaging & Diagnostics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Caliber Imaging & Diagnostics had a market capitalisation of $0.00m.
Here are the trading details for Caliber Imaging & Diagnostics:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: LCDX
Based on an overall assessment of its quality, value and momentum Caliber Imaging & Diagnostics is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Caliber Imaging & Diagnostics. Over the past six months, its share price has underperformed the S&P500 Index by -71.11%.
As of the last closing price of $0.00, shares in Caliber Imaging & Diagnostics were trading -99.42% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Caliber Imaging & Diagnostics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Caliber Imaging & Diagnostics' directors